Steward Partners Investment Advisory LLC Acquires Shares of 1,285 Everus (NYSE:ECG)

Steward Partners Investment Advisory LLC acquired a new stake in shares of Everus (NYSE:ECGFree Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,285 shares of the company’s stock, valued at approximately $84,000.

A number of other large investors have also recently added to or reduced their stakes in ECG. Forza Wealth Management LLC bought a new position in Everus during the 4th quarter valued at $336,000. Mendota Financial Group LLC bought a new position in Everus during the 4th quarter valued at $36,000. SeaCrest Wealth Management LLC bought a new position in Everus during the 4th quarter valued at $292,000. Hennessy Advisors Inc. bought a new position in Everus during the 4th quarter valued at $31,611,000. Finally, Brady Martz Wealth Solutions LLC bought a new position in Everus during the 4th quarter valued at $472,000.

Insider Activity at Everus

In related news, Director Rocca Michael Della purchased 1,050 shares of the company’s stock in a transaction on Tuesday, February 18th. The shares were bought at an average cost of $47.56 per share, for a total transaction of $49,938.00. Following the transaction, the director now owns 2,027 shares of the company’s stock, valued at $96,404.12. This represents a 107.47 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Maximillian J. Marcy purchased 1,300 shares of the company’s stock in a transaction on Tuesday, February 25th. The shares were bought at an average price of $38.99 per share, for a total transaction of $50,687.00. Following the completion of the transaction, the chief financial officer now directly owns 5,508 shares in the company, valued at $214,756.92. This represents a 30.89 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 3,750 shares of company stock worth $153,853 in the last ninety days.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on ECG. Wolfe Research began coverage on shares of Everus in a research report on Tuesday, December 3rd. They issued a “peer perform” rating on the stock. Stifel Nicolaus reduced their price target on shares of Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Oppenheimer raised their price target on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 7th.

Get Our Latest Analysis on ECG

Everus Stock Performance

Everus stock opened at $39.00 on Tuesday. The business has a 50-day simple moving average of $56.59. Everus has a 1 year low of $37.00 and a 1 year high of $77.93. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58.

Everus (NYSE:ECGGet Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.73 by ($0.06). On average, equities research analysts forecast that Everus will post 2.49 earnings per share for the current year.

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

See Also

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.